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Genes associated with similar diseases are often functionally related. This principle is largely supported by many biological 
data sources, such as disease phenotype similarities, protein complexes, protein-protein interactions, pathways and gene ex-
pression profiles. Integrating multiple types of biological data is an effective method to identify disease genes for many genetic 
diseases. To capture the gene-disease associations based on biological networks, a kernel-based Markov random field (MRF) 
method is proposed by combining graph kernels and the MRF method. In the proposed method, three kinds of kernels are em-
ployed to describe the overall relationships of vertices in five biological networks, respectively, and a novel weighted MRF 
method is developed to integrate those data. In addition, an improved Gibbs sampling procedure and a novel parameter estima-
tion method are proposed to generate predictions from the kernel-based MRF method. Numerical experiments are carried out 
by integrating known gene-disease associations, protein complexes, protein-protein interactions, pathways and gene expression 
profiles. The proposed kernel-based MRF method is evaluated by the leave-one-out cross validation paradigm, achieving an 
AUC score of 0.771 when integrating all those biological data in our experiments, which indicates that our proposed method is 
very promising compared with many existing methods. 
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The availability of large-scale biological networks provides 
an opportunity to comprehensively identify disease genes of 
many genetic diseases, by synergizing evidences from mul-
tiple types of data sources. Various algorithms [1–6] have 
been developed to identify human disease genes based on 
the strategy of multiple data integration.  
However, challenges still exist due to the following rea-
sons. Firstly, there are many levels of controls along paths 
from genotypes to phenotypes [7], resulting in the indirect 
relationship between genotypes and phenotypes [8]. Sec-
ondly, different biological data are heterogeneous and de-
scribe relationships of molecular entities in various levels. It 
is not a trivial task to design a good algorithm that combines 
those data appropriately. Thirdly, many data integration 
methods simply assume that disease genes of similar dis-
eases exhibit dense clusters in the integrated networks, but 
ignore the fact that those networks are built independently 
from the description of gene-disease association relation-
ships.  
The Markov random field (MRF) model proposed by 
Deng et al. [9,10] for predicting yeast protein functions pro-
vides a good framework to integrate multiple biological 
networks. The issue of protein function prediction is formu-
lated as a Bayesian labeling problem, where the function  
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labels follow a Gibbs distribution. A binary logistic regres-
sion is employed to estimate parameters from known ob-
servations, and a Gibbs sampling approach is developed to 
generate final predictions. Advantages of the MRF method 
include its simplicity, its ability to explore contributions of 
direct neighbors, and its flexibility to integrate multiple 
types of datasets. 
Although the issue of yeast protein function prediction is 
similar to the issue of human disease gene identification, the 
method of Deng et al. [9,10] cannot be directly employed to 
identify human disease genes. Parameters of the MRF mod-
el cannot be estimated precisely due to the limited observa-
tions of human disease genes, which make predictions of 
their method unreliable. Kourmpetis et al. [11] then pro-
posed a Bayesian MRF method to estimate parameters iter-
atively together with the update of posterior probabilities of 
function labels during the Gibbs sampling process. However, 
their method uses another predefined scaling parameter , a 
Z matrix and a multivariate normal distribution to perform 
the estimation, which makes the method a little complex. 
Ma et al. [5] proposed a combining gene expression and 
protein interaction data (CGI) method to identify genes re-
sponsible for similar phenotypes or traits, motivated from 
the MRF model of Deng et al. [9,10]. Similarity metric de-
fined by the diffusion kernel is also compared with those by 
direct neighbors and shortest paths, where predictions from 
the diffusion kernel are greatly improved. However, the 
CGI method mainly uses gene expression profiles to group 
genes with similar characters. Protein interaction data are 
only employed to calibrate predictions. It is not clear how to 
integrate other types of biological data by using their meth-
od. Lee et al. [12] developed a kernel logistic regression 
(KLR) method for predicting yeast protein functions by 
combining advantages of both the MRF model and diffusion 
kernels. Although its predictive accuracy is higher than that 
of the original MRF method of Deng et al. [9,10], the pa-
rameter estimation problem still exists if the KLR method is 
employed to identify human disease genes. Other forms of 
MRF methods can be found in [13–15]. 
Graph kernels, on the other hand, have shown their pow-
ers for interpreting complex relationships of vertices in bio-
logical networks [16–18]. A kernel-based algorithm often 
yields better performance than those using direct neighbors 
or shortest paths under the same condition. In papers 
[19,20], we have developed a modified MRF model for 
human disease gene prioritization. In this study, we further 
propose a kernel-based MRF algorithm for identifying dis-
ease genes from multiple types of data by combining the 
MRF model and graph kernels. The kernel-based MRF al-
gorithm is different from the methods proposed in [19,20] in 
the following four aspects. Firstly, a novel weighted MRF 
method is developed for incorporating different graph ker-
nels. Secondly, a new parameter estimation method is de-
signed for the kernel-based MRF method based on global 
characters of biological networks. Thirdly, an improved 
Gibbs sampling strategy is proposed which takes the weight 
value of neighbors into consideration, rather than simply 
counting the number of neighbors attributed specific values. 
Finally, the kernel-based MRF method is extended to inte-
grate multiple types of data sources, such as protein-protein 
interaction (PPI) networks, pathway co-existing networks 
and gene co-expression networks. We show that the ker-
nel-based MRF algorithm can significantly improve the 
accuracy of disease gene identification compared with ex-
isting methods. 
1  Methods 
1.1  Problem statement 
Suppose a human genome consists of a set of N genes 
1 2{ , ,..., }Ng g g . Some of them have already been known to 
be associated with r genetic diseases, while associations of 
most others are still not known and need to be determined. 
Let {D1, D2,..., Dr }  be those r associated diseases. Each 
Di  consists of a set of known disease genes of the ith dis-
ease. Hence, the number of all those known disease genes 
equals m  , where *  is the cardinali-
ty of the set. Without loss of generality, let 
mnnn ggg  ,,, 21   be those known disease genes, and 
nggg ,,, 21   be all others, where N=n+m. 
For a specific disease, let 1 2( ,  , ,  )n mx x x x    be a 
vector of binary variables (i.e., taking values zero or one) 
defined on all genes, where xi 1 represents gene gi  to 
be a disease gene of the disease and xi  0  otherwise. The 
purpose of disease gene identification is to predict values of 
miss
1 2( , , , )nx x x x   from current known values 
obsx  ),,,( 21 mnnn xxx   . To achieve this, a vector of ran-
dom variables ),,,( 21 NXXXX   is defined corre-
sponding to x , where P(Xi  xi ) represents the probabil-
ity that Xi  xi . The objective is to find the posterior prob-
ability of nXXX ,,, 21   conditional on known disease 
genes, 
 ),,,,,( 121 mnnn XXXXXP   . (1) 
1.2  Markov random field 
Let G  (V, E)  be a graph with N vertices and 
),,,( 21 NXXXX   be a vector of random variables de-
fined on V. The vector X is said to be a MRF on G if and 
only if the following two conditions are satisfied: 
(i) Positivity: P(Xi )  0 , Xi  X , 
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(ii) Markovianity: P(Xi X[i ] )  P(Xi XN (i ) ),  
where X  are the set of all possible outcomes of Xi ,  
X[i ]  is the collection of random variable 
),,,,,( 111 Nii XXXX   , and XN (i)  is the collection of 
all X j  for j  N (i), where N(i) is the set of all neigh-
bors of vertex i in G. The neighborhood structure of graph 
G is denoted as N . The Markovianity indicates that the 
probability of Xi  is conditionally independent on all other 
Xk  except the value of its neighbors. A joint event 
},,{ 11 NN xXxX   , abbreviated as X  x , is a realiza-
tion of X, where ),,,( 21 Nxxxx   is called a configura-
tion of X. 
One of the key features that facilitate the practical usage 
of MRF is its equivalence with the Gibbs random filed, 
which is established by the Hammersley-Clifford theorem 
[21,22]. According to the theorem, X is a MRF on V w.r.t. 
N  if and only if the probability distribution of P(X)  
follows a Gibbs distribution. The Gibbs distribution has a 
form of 
 P(X  x)  Z 1eU ( x )/T , (2) 
where Z  eU ( x )/T
xX  is a normalizing constant called 
partition function, T is a global control constant called tem-
perature, which is often assumed to be 1 unless otherwise 
stated, and U(x)  is called the energy function, which can 
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where Vi (x)  is the clique potential of Ci  (the set of ith 
order cliques in G), Rn (x)  represents those higher order 
terms. A special case of MRF is the Ising model that only 
considers up to the second order of cliques [24], which is 
also the same as many existing MRF methods did in 
[10,11,20]. 
The practical valuation of the Hammersley-Clifford the-
orem is that it gives a simple way to specify the probability 
P(X)  by using those clique potentials. Suppose Xi  is a 
binary random variable (i.e., taking values zero or one). Let 
V1(xi )    xi , V2 (1,1)  11 , V2 (1, 0) V2 (0,1)  10 , and 
V2 (0, 0)  00 . Let N11 , N10  and N00  be the number of 
edges whose two endpoints have both the attribute values of 
1, one attribute value of 1 and the other value of 0, and both 
the attribute values of 0, respectively. Then the energy func-
tion (3) of the MRF can be written as 
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where   (,11,10,00 )  are parameters. 
To generate predictions from a MRF model, the value of 
parameter   is necessary, which is generally unknown. 
The most natural approach to estimate   is through the 
maximum likelihood estimation (MLE) method. However, 
the MLE method is often intractable in this situation, since 
the normalizing partition function Z is also a function of 
parameters. Fortunately, the pseudo-likelihood approach 
and the Gibbs sampling process provide a solution for esti-
mating parameters and generating predictions from a MRF 
model. 
Firstly, for estimating parameters, suppose parameters 
  (,11,10,00 )  of (4) are given. Then fixing the value 
of Xi , the energy function of (4) can be rewritten as 
 
U(Xi 1, X[i ]  )
           U(X[ i ]  )  11 xj
jN (i )
 10 (1 x j )
jN (i )
  (5) 
and 
 
U(Xi  0, X[i ]  )
          U(X[i ]  ) 10 xj
jN (i )
 00 (1 xj )
jN (i )
  (6) 
respectively, where U(X[i ]  )  represents the energy con-
tributed by all cliques that do not contain vertex i. 
Hence, according to the Bayes’ theorem [25] and (2), (5) 
and (6), we have 
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The log-odds of the probability P(Xi 1 X[i ], ) is 
 log
P(Xi 1 X[i ], )
1P(Xi 1 X[ i], )  1Mi1 0Mi0 , (8) 
where 1  (11 10 ) , 0  (10  00 ), and Mi1 , Mi0  are 
the number of neighbors of gene i whose x j  are attributed 
with value of 1 and 0 in G, respectively. Those parameters 
of the MRF method can be estimated by using the standard 
MATLAB function glmfit(). 
Secondly, for the Gibbs sampling process, it is a type of 
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Markov Chain Monte Carlo (MCMC) algorithm. Given a 
set of probabilities X (t ) at time t, it iteratively updates the 
value of X according to the univariate conditional distribu-
tion P(Xi 1 X[i ], ) as follows: 
 
( 1) ( ) ( ) obs
1 1 2
( 1) ( 1) ( ) ( ) obs
2 2 1 3
( 1) ( 1) ( 1) ( ) ( ) obs
3 3 1 2 4
( 1) ( 1) ( 1) obs
1 1
( , , , , )
( , , , , , )
( , , , , , , )
         
( , , , , )
t t t
n
t t t t
n
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where obs 1( , , )n n mX X X   . The Gibbs sampling process 
always uses the most recent values of Xi  to update succes-
sive variables. The sequence (1) (2) (3), , ,X X X  clearly 
forms a Markov chain. 
1.3  Graph kernels 
Kernels provide a general framework to represent data in 
the form of pairwise similarities. Generally, two mathemat-
ical conditions need to be satisfied that make a function k 
serving as a kernel: (i) it must be symmetric 
( ( , ) ( , ))i j j ik x x k x x  and (ii) positive semi-definite. Math- 
ematically, for any kernel function k on a space X , there 
exists a Hilbert space H  and a mapping  : X H , 
such that 
 ( , ) ( ), ( ) ,   for any ,i j i j i jk x x x x x x  X , (10) 
where u, v  represents the dot product in the Hilbert 
space between any two points u, v H . 
The definition of a kernel is a critical component of any 
kernel method, since it defines how an algorithm “sees” the 
data. The graph representation of a biological network is 
often used to describe local topological relationships, which 
is often not enough to capture the distant relationships 
among biomolecules. Alternately, a graph kernel based rep-
resentation provides a solution for this by considering glob-
al topological structures [16,18]. 
One of the most commonly used graph kernel of G is the 
Laplacian exponential diffusion (LED) kernel [16], where 
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 (11) 
where L D A   is the Laplacian matrix of the graph G, A 
is the adjacency matrix, and D is a diagonal matrix with the 
ith diagonal element d(i)  being the degree of the vertex i 
and all off-diagonal elements being 0. The parameter   
controls the magnitude of the diffusion, which is often cho-
sen as a very small number. In this study, we take   0.04  
as [7] suggested. 
A diffusion kernel defines the similarity of biomolecule 
pairs by considering all pairwise relationships within a net-
work. However, diffusion kernels between different biolog-
ical networks may not be comparable when a method needs 
to integrate multiple data sources. To overcome this prob-
lem, Chen et al. [7] propose a measure, called DKPC, to 
normalize pairwise similarities based on their relative 
strengths among all similarities within a network. The 
DKPC value between a vertex pair i and j is defined as 
 
{( , ) }
( , ) ,
{( , ) 0}
st ij
st
s t K K
DKPC i j
s t K
   (12) 
where ijK  is a similarity value of vertex pair i and j in a 
kernel matrix. A smaller value of DKPC(i, j)  indicates 
that two vertices i and j are more similar. However, in   
the KLED matrix, it uses larger values to represent relation-
ships of vertices are more similar. To be consistent, we use 
the complementary value DKPCij 1DKPC(i, j)  to rep-
resent the normalized similarity between vertex pair i and j 
that is obtained from the DKPC method hereafter. 
Generally, the above two kernels are strongly related to 
the degree of individual vertices, where the kernel value 
between two high degree vertices is significantly different 
from that between two low degree vertices. To make the 
strength of individual vertices comparable, we propose a 
Markov exponential diffusion (MED) kernel in this study by 
replacing the Laplacian matrix L in (11) with a Markov ma-
trix M, which consists of nonnegative real numbers with 
each row and column summing to 1. The MED kernel ma-





( ) ( )














     
    
 (13) 
where M  (N  I D A) N  and N is the number of ver-
tices in the network. 
1.4  Kernel-based MRF method 
Let KNN  be a kernel matrix derived from a biological 
network, where all diagonal elements are set to be zero 
(since the purpose of disease gene identification is to obtain 
a set of novel candidate genes according to the knowledge 
of known disease genes, the similarity metrics between a 
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gene and itself are neglected). Let ),,,( 21 Npppp   be a 
vector of probabilities, where pi  represents the probability 
of Xi 1 conditional on all other variables X[i ]  given the 
parameter  . We propose the kernel-based MRF method in 
three steps as follows. 
Firstly, let ),,,( 21 Nxxxx   be a set of configuration 
obtained from p. In the KLR method of Lee et al. [12], the 
weighted number of neighbors whose x j  values are at-
tributed with 1 and 0 for gene i are defined as 
 1 0
1 1
    and    (1 )
N N
w w
i ij j i ij j
j j
M K x M K x
 
       (14) 
respectively, where Kij  is the entry in the ith row and jth 
column of the matrix KNN . It should be noticed that the 
values of Mi1
w  and Mi0
w  are highly dependent on values of 
all x j , which are randomly generated from those pj . To 
reduce the dependence, the x j  in (14) can be replaced di-
rectly by using those pj . Thus, the improved weighted 
number of neighbors can be written as 
 ' '1 0
1 1
    and    (1 )
N N
w w
i ij j i ij j
j j
M K p M K p
 
      . (15) 
The log-odds of the probability P(Xi 1 X[i ], )  in 
weighted form is then defined as 
 log
P(Xi 1 X[i ], )
1P(Xi 1 X[ i], )  1Mi1
w '  0Mi0w ' . (16) 
Secondly, an improved Gibbs sampling method is proposed 
that can iteratively estimate and update parameters   sim-
ultaneously with the change of posterior probabilities. Sup-
pose a prior probability of p(0)  is given for all vertices. A 
set of prior configuration ),,( 001
)0(
Nxxx   can be ran-
domly generated according to the prior probability. Then 
the pseudo-likelihood parameter estimation method can be 
performed on the whole network, including those known 
vertices and those unknown vertices, by using (16). Once 
those parameters are obtained in this iteration, the posterior 
probabilities of each vertex pi  can then be updated ac-
cording to (16) as well. Repeat this process for many times 
until both of them are stable. The step-by-step description of 
this Gibbs sampling procedure is given as follows. 
S1. Initialization: 
Let t  0 . Initialize the prior probabilities for unknown 
vertices (0) (0) (0)1 2( , , , )np p p  and known vertices 
obs
1 2( , , , )   n n n mp p p p  respectively. 
S2. Parameter estimation: 
Assign a configuration of ( ) ( ) ( )1( , , )
t t t
Nx x x   and cal-
culate the values of Mi1
w '  and Mi0
w '  according to the value 
of ( ) ( ) ( ) obs1( , , , ) t t tnp p p p . Estimate parameters  ( t )  
based on (16). 
S3. Gibbs sampling: 
 
( 1) ( ) ( ) obs ( )
1 1 2
( 1) ( 1) ( ) ( ) obs ( )
2 2 1 3
( 1) ( 1) ( 1) obs ( )
1 1
( 1 , , , , )
( 1 , , , , , )
         
( 1 , , , , )
t t t t
n
t t t t t
n
t t t t
n n n
p P X p p p
p P X p p p p
















S4. Let t  t 1, and go to S2, until t  is larger than a 
predefined iteration step. 
The details of how this predefined iteration step is set are 
given in the Experimental design section. The improved 
Gibbs sampling procedure above is different from existing 
MRF methods [10,13,23] in two aspects. First, parameters 
of the improved method are estimated according to the con-
figuration and the posterior probability of the whole net-
work, while most existing MRF methods are based on sub-
networks that consist of only known vertices. Ignoring the 
majority of unknown vertices makes the value of Mi1  and 
Mi0  (or Mi1
w '  and Mi0
w '  in this study) inaccurate, and then 
parameters cannot be estimated precisely. Predictions be-
come unreliable if those inaccurate parameters are used to 
identify human disease genes. Second, many existing MRF 
methods estimate parameters only once. Parameters are then 
fixed during the entire Gibbs sampling process [10,13,23]. 
This is very dangerous if parameters are not estimated pre-
cisely. In our method, parameters are updated iteratively 
together with the change of all posterior probabilities. The 
Gibbs sampling process always takes the most updated pa-
rameters to estimate posterior probabilities for all unknown 
vertices, which is expected to generate more reliable predic-
tions. 
Finally, the proposed MRF method is extended for in-
corporating multiple types of biological networks. Suppose 
there are L networks 1( , , )LH H H  , where vertices 
represent genes and edges represent specific biological rela-
tionship between vertices. Eq. (16) can be easily extended 
as 
 log
P(Xi 1 X[i ], )
1P(Xi 1 X[i ], )   1
lMi1
w ' l 0l Mi0w 'l 
l1
L  (17) 
by simply summing the effect of the weighted number of 
neighbors Mi1
w 'l  and Mi0
w 'l  for gene i from all L networks, 
where 1 11 0 1 0( , , , , , )
L L        are parameters. The con-
tribution of a network H l  can be adjusted through the 
value of 1l  and 0l  accordingly. The improved Gibbs 
sampling procedure can be easily performed by replacing 
 Chen BL, et al.   Sci China Life Sci   November (2014) Vol.57 No.11 1059 
(16) with (17), when estimating parameters and updating 
posterior probabilities during the iterations. 
1.5  Experimental design 
1.5.1  Data Sources 
Known gene-disease associations are collected from the 
Morbid Map list of the Online Mendelian Inheritance in 
Man (OMIM) [26]. Goh et al. [27] classify all those diseas-
es into 22 primary disease classes, including a ‘multiple’ 
class and an ‘unclassified’ class. The dataset consists of 
1284 diseases and 1777 disease genes. In this study, we 
choose those disease classes that consist of at least 30 genes 
and exclude the ‘multiple’ class, the ‘unclassified’ class, the 
‘cancer’ class and the ‘neurological’ class due to the lack of 
their class evidence and the class heterogeneity [27]. The 
final dataset consists of 815 genes in 12 disease classes. 
Two sets of protein complexes are collected from the da-
tabase of CORUM [28] and PCDq [29], which contain 1677 
and 1103 protein complexes that consist of at least two  
proteins, respectively. All those protein complexes are   
employed to assign the prior probabilities for unknown  
vertices. 
Three PPI networks are derived from the database of 
HPRD (Release 9) [30], BioGrid (Release 3.2.108) [31] and 
IntAct (downloaded on Jan 26, 2014) [32], respectively. 
Duplicated edges and loop edges are deleted. The HPRD 
PPI network consists of 9465 vertices and 37039 edges. The 
BioGrid PPI network consists of 15298 vertices and 127612 
edges. The IntAct PPI network consists of 13449 vertices 
and 63825 edges. These PPI networks have been widely 
used to identify protein complexes [3336] or essential 
proteins [3739] and thus can be considered to be reliable 
data. 
Pathway datasets are obtained from the database of 
KEGG [40], Reactome [41], PharmGKB [42] and PIN [43], 
which contain 280, 1469, 99 and 2679 pathways, respec-
tively. A pathway co-existing network is constructed by 
taking individual proteins/genes as vertices. Edges are con-
structed between two vertices if they co-exist in any path-
way. 
A gene co-expression network is constructed by using 
the dataset of BioGPS (GSE1133) [44,45]. It contains 79 
human tissues in duplicates, which are measured by using 
the Affymetrix U133A array. Pairwise Pearson correlation 
coefficients (PCC) are calculated and a pair of genes are 
linked by an edge if the PCC value is larger than 0.5, similar 
to the method used in [7,27]. 
Overall, five biological networks are constructed and all 
protein (or gene) IDs are mapped onto the form of the gene 
symbol. In order to test the performance of multiple data 
integration of our method, we select those genes that appear 
at least in four networks. The final datasets consist of 7311 
human genes, 815 out of which are known to be associated 
with 12 disease classes. 
1.5.2  Estimating a prior probability 
To perform a Gibbs sampling procedure, a set of prior 
probabilities for all vertices is needed. Generally, the values 
of those prior probabilities do not have significant effect on 
the final stabled state of a Markov chain if enough iterations 
are performed. However, a good prior does help to reduce 
the time of iterations to achieve the stable state. 
For those known disease genes, the prior probability of 
obs
1( , , )n n mp p p    can be assigned determinedly ac-
cording to known gene-disease associations. The value of 
pj , n1 j  nm  equals 1 or 0 depending on the ana-
lyzed disease class and those known gene-disease associa-
tions. 
For those unknown disease genes, since genes that en-
code proteins in a same complex tend to associate with sim-
ilar diseases, we estimate their prior probabilities according 
to the protein complex information, similarly to the method 
used in Deng et al. [9,10]. For a gene gi  that encodes pro-
tein in a complex, let 
 pˆi  AB  (18) 
be the prior probability, where A is the number of disease 
genes for a specific disease in the complex, and B is the 
number of all disease genes in the complex. If a gene ap-
pears in multiple protein complexes, we use the maximum 
value as the prior probability for the gene. For those genes 
that do not belong to any protein complex, let 
 pˆi  CD  (19) 
as the prior probability, where C is the number of all cur-
rently known disease genes for the specific disease, and D is 
the total number of genes in human genome. 
1.5.3  Specifying an iteration loop 
During the Gibbs sampling procedure, a “burn-in period” 
and a “lag period” often need to be specified. The “burn-in 
period” is the period that a Markov chain takes to become 
stabilized. Simulation results in this period are discarded to 
reduce the effect of initial prior probabilities. The “lag pe-
riod” is the period that needs to reduce the dependence of 
the Markov process. The posterior probabilities in this pe-
riod are estimated by averaging simulation results during 
individual lag steps. In paper [20], we have shown that an 
additional “prediction period” is helpful to generate more 
stable and reliable predictions, which is the period used to 
generate final prediction by averaging all simulation results 
during this period.  
In this study, the “burn-in period” takes 100 steps, the 
“lag period” takes 90 steps and the “prediction period” takes 
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100 steps. Simulation results are averaged every 10 steps in 
the “lag period”. There are 1100 steps in total for simula-
tions. 
1.5.4  Validation method and evaluation criteria 
The leave-one-out cross validation paradigm is employed to 
evaluate the proposed method. For each known disease gene 
with at least one annotated interaction partner in a biologi-
cal network, we assume it is an unknown gene and predict 
its posterior probability by the proposed method. The re-
ceiver operating characteristic (ROC) curve is employed as 
one of the evaluation criteria, which shows the relationship 
between the true positive rate (TPR) and the false positive 
rate (FPR) by varying the threshold for declaring positives. 
The area under the ROC curve (AUC) is also employed to 
show an overall performance of an algorithm. The negative 
control set consists of known disease genes that do not be-
long to the current disease class, and they are also validated 
by using the leave-one-out cross validation paradigm. The 
application of the AUC score as the evaluation criterion is 
due to the fact that it is widely accepted by most research-
ers. 
We compare the proposed method with four existing al-
gorithms: (i) the random walk with restart (RWR) algorithm 
proposed by Köhler et al. [46]; (ii) the data integration rank 
(DIR) algorithm proposed by Chen et al. [7]; (iii) the origi-
nal MRF method proposed by Deng et al. [10] (denoted as 
MRF-Deng hereafter) and (iv) our previous improved MRF 
method for identifying human disease genes [20] (denoted 
as IMRF hereafter). The RWR algorithm [46] is a typical 
data integration method that uses a mixed network, where 
vertices and edges of several biological networks are simply 
merged together, while our proposed method integrates 
those networks separately. The comparison between those 
two algorithms can show which manner of multiple data 
integration is better. The DIR algorithm [7] has a very good 
performance in terms of multiple data integration. It also 
employs diffusion kernels to integrate different networks 
separately, which yields better performance than many other 
data integration methods [7]. The comparison with the other 
two existing MRF methods demonstrates how much im-
provement can be obtained from the proposed method as 
well. 
1.5.5  Decision score and declaration of positives 
Different disease classes consist of different numbers of 
known disease genes, and thus the prediction results may 
not be good if a global threshold is used for all classes. Alt-
hough one can directly use the posterior probabilities ob-
tained from the Gibbs sampling to select candidate disease 
genes, we suggest using a percentage as a decision score to 
generate the finial predictions. Let ( ) ( ) ( ) ( )1 2( , , , )
T T T T
np p p p   
be the set of final posterior probabilities for a specific dis-
ease class. The decision score qi  of vertex i is defined as 
 









The greater the decision score is for a gene, the more likely 
it is to associate with specific disease. All the ROC curves 
and the AUC scores of the proposed method are calculated 
according to the decision score hereafter. 
2  Results 
2.1  Stability and reliability of the kernel-based MRF 
method 
We first investigate the stability and reliability of the ker-
nel-based MRF method, by comparing the Markov process-
es of the proposed method and the MRF-Deng method. 
Figure 1 illustrates the variation of posterior probabilities 
over iteration steps and the final posterior probability dis-
tribution for the above two methods. 
Firstly, by comparing Figure 1A and C, we can clearly 
find that the kernel-based MRF method is more stable than 
the MRF-Deng method. The change of posterior probability 
of the front method converges quickly and stays at a stable 
state. 
Here, the variation of posterior probabilities for two 
consecutive steps is calculated from 







Q t p p 

   (20) 
where pi
(t )  is the posterior probability P(Xi 1 X[i ], ) of 
gi  obtained in the tth iteration. 
Secondly, predictions of the kernel-based MRF method 
are more reasonable compared with the MRF-Deng method. 
The parameters of the MRF-Deng method are estimated 
from subnetworks of known vertices, which may only be 
feasible when the subnetwork is large enough for estimating 
parameters precisely. When the MRF-Deng method is em-
ployed directly to identify human disease genes, there are 
approximately 25.82% unknown genes that are predicted as 
disease genes with a probability large than 0.95. This is un-
reasonably high in practice, since it contains too many false 
positive predictions. Figure 1D shows the final posterior 
probability distribution of the MRF-Deng method as an 
example. 
On the other hand, the kernel-based MRF method works 
very well. Taking the endocrine disease class for example, 
which is illustrated in Figure 1B, most genes are predicted 
with a probability small than 0.1. Only a few significant 
vertices are predicted with higher probabilities. Predictions 
of the kernel-based MRF method are more reliable than the 
MRF-Deng method. 
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Figure 1  Analyses of stability and reliability of MRF methods (by using single HPRD PPI network for endocrine disease class). A, The variation of poste-
rior probabilities over iteration steps of the kernel-based MRF method. B, The posterior probability distribution of the kernel-based MRF method. There are 
only 3.77% of unknown vertices which are predicted with probability larger than 0.1, which means only a small amount of significant vertices are predicted 
with higher probabilities. C, The variation of posterior probabilities over iteration steps of the MRF-Deng method. D, The posterior probability distribution 
of MRF-Deng method. There are almost 25.82% of unknown vertices that are predicted with probability larger than 0.95, which means too many vertices are 
predicted with very high probabilities. 
2.2  Comparisons between different kernels 
To test the contribution of graph kernels in the kernel based 
MRF method, three types of kernels are employed in our 
experiments. Figure 2 illustrates the cross-validation results 
in terms of ROC curves and the AUC score by integrating 
only three PPI networks and all five biological networks, 
respectively. The LED kernel achieves the best performance 
(AUC=0.753) when three PPI networks are integrated, 
while the MED kernel works best (AUC=0.771) when all 
five PPI networks are integrated. The similar performance 
of those kernels also supports the stability of the kernel 
based MRF method. 
Generally, there is no such a kernel that works better than 
all other kernels in any situation. The LED kernel works 
better than the MED kernel when three networks are inte-
grated. However, the difference of between those two AUC 
scores is not large in this situation. Besides, the MED kernel 
works much better than the LED kernel when five networks 
are integrated. Hence, the MED kernel is always suggested 
to be used for multiple data integration if no particular in-
formation is obtained. 
2.3  Comparisons with existing methods 
The kernel-based MRF method is compared with the RWR 
algorithm, the DIR algorithm, the MRF-Deng algorithm and 
the IMRF method. Figure 3 illustrates ROC cross-validation 
results by integrating all five biological networks. It can be 
seen from the figure that the kernel based MRF method 
performs best compared with the other four existing algo-
rithms. The kernel-based MRF method achieves the highest 
AUC score at 0.771 by using the MED kernel, followed by 
the IMRF method (AUC=0.743), the DIR algorithm 
(AUC=0.691) and the RWR algorithm (AUC=0.676). The 
MRF-Deng method achieves the AUC score only at 0.551. 
3  Discussion 
In this paper, we have presented an improved kernel based 
MRF method for identifying human disease genes by inte-
grating five biological networks. The presented method is 
not only flexible in terms of integrating different types of 
biological data, but also reliable in terms of identifying hu-
man disease genes. Three kinds of graph kernels are em-
ployed to capture relationships of all vertices based on their 
global neighborhood characteristics. An improved Gibbs 
sampling procedure and a novel parameter estimation 
method are then developed for the presented MRF method. 
The use of different kernels brings great improvement for 
the previous MRF method. The proposed MED kernel 
works similar to the most commonly used LED kernel when 
three PPI networks are integrated, and it works best when 
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Figure 2  Comparisons of different kernels by using the kernel-based MRF method. A, Comparisons of ROC curves by integrating all five biological net-
works. B, Comparisons of ROC curves by integrating only three PPI networks. The red lines are ROC curves by using the LED kernels. The green lines are 
ROC curves by using the ijDKPC . The blue lines are ROC curves by using the MED kernels. AUC values are listed in parentheses. 
 
Figure 3  ROC curves of cross-validation results of different methods 
with integrating five biological networks. The blue solid line represents the 
ROC curve by using the kernel-based MRF method. The red solid line 
represents the ROC curve by using the IMRF method. The cyan dash-dot 
line represents the ROC curve by using the DIR method. The magenta 
dash-dot line represents the ROC curve by using the RWR method. The 
green solid line represents the ROC curve by using the MRF-Deng method. 
AUC values are listed in parentheses. 
five biological networks are integrated. Hence, the MED 
kernel is suggested to be used for the proposed algorithm 
when multiple data integration is involved to predict disease 
genes. Predictions by our presented method with integrating 
all five biological networks achieve the AUC score of 0.771 
when the MED kernel is employed, which is very promising 
for identifying human disease genes. 
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